ALPHANINE SD (factor IX)
FACTOR IX · HEMOPHILIA B
GRIFOLS
Drug class
Factor IX
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins. Read more about Factor IX
10 drugs in this class 8 manufacturers
Drugs in Factor IX
PROFILNINE (factor IX complex, prothrombin complex conc no.4, 3-factor)
FACTOR IX · HEMOPHILIA B
GRIFOLS
RIXUBIS (factor IX human recombinant)
FACTOR IX · HEMOPHILIA B
BAXALTA US INC.
BENEFIX (factor IX human recombinant)
FACTOR IX · HEMOPHILIA B
Wyeth Pharmaceutical
REBINYN (factor IX (human) recombinant, pegylated)
FACTOR IX · HEMOPHILIA B ·+1
NOVO NORDISK
ALPROLIX (factor IX recombinant, Fc fusion protein)
FACTOR IX · HEMOPHILIA B
BIOVERATIV THER
KCENTRA (human prothrombin complex concentrate 4-factor)
FACTOR IX · ANTICOAGULANT-INDUCED PROTHROMBIN DEFICIENCY
CSL Behring
IDELVION (factor IX recombinant,albumin fusion protein)
FACTOR IX · HEMOPHILIA B
CSL Behring
IXINITY (factor IX human recombinant, threonine 148)
FACTOR IX · HEMOPHILIA B ·+2
MEDAC PHARMA, I
Filter & compare in the drug finder →
Opens the drug finder with Factor IX preselected. Add indication or manufacturer filters there.
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins.
They function by replenishing deficient or functionally absent intrinsic coagulation factor IX, which activates factor X in the blood clotting cascade to facilitate normal thrombin generation and stable fibrin clot formation.
This drug class is primarily indicated for the treatment, routine prophylaxis, and perioperative management of bleeding episodes in pediatric and adult patients with hemophilia B, also known as Christmas disease.
-
fda.gov
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins
-
wfh.org
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins
-
nih.gov
Factor IX products constitute a therapeutic class of hemostatic clotting factor replacement therapies comprising human plasma-derived and recombinant coagulation proteins
-
medlineplus.gov
They function by replenishing deficient or functionally absent intrinsic coagulation factor IX, which activates factor X in the blood clotting cascade to facilitate normal thrombin generation and stable fibrin clot formation
-
nih.gov
They function by replenishing deficient or functionally absent intrinsic coagulation factor IX, which activates factor X in the blood clotting cascade to facilitate normal thrombin generation and stable fibrin clot formation
-
fda.gov
This drug class is primarily indicated for the treatment, routine prophylaxis, and perioperative management of bleeding episodes in pediatric and adult patients with hemophilia B, also known as Christmas disease
-
fda.gov
This drug class is primarily indicated for the treatment, routine prophylaxis, and perioperative management of bleeding episodes in pediatric and adult patients with hemophilia B, also known as Christmas disease
-
bleeding.org
This drug class is primarily indicated for the treatment, routine prophylaxis, and perioperative management of bleeding episodes in pediatric and adult patients with hemophilia B, also known as Christmas disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.